Dialysis is a vital treatment for patients with kidney failure on dialysis (KF). Yet, it associates with a high risk of death mainly due to both cardiovascular (CV) and non-CV causes [1,2]. Indeed, the overall mortality rate for CV causes is about ten times higher in these patients when compared to the general population [3] and CV comorbidity such as coronary artery disease and heart failure are highly prevalent in this population [4].
